Shell Plc ADR (SHEL) concluded trading on Thursday at a closing price of $66.45, with 3.62 million shares of worth about $240.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.32% during that period and on January 16, 2025 the price saw a gain of about 0.14%. Currently the company’s common shares owned by public are about 3.12B shares, out of which, 3.12B shares are available for trading.
Stock saw a price change of 2.67% in past 5 days and over the past one month there was a price change of 4.58%. Year-to-date (YTD), SHEL shares are showing a performance of 6.07% which increased to 7.59% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.15 but also hit the highest price of $74.61 during that period. The average intraday trading volume for Shell Plc ADR shares is 4.27 million. The stock is currently trading 5.01% above its 20-day simple moving average (SMA20), while that difference is up 2.90% for SMA50 and it goes to -3.79% lower than SMA200.
Shell Plc ADR (NYSE: SHEL) currently have 3.12B outstanding shares and institutions hold larger chunk of about 11.67% of that.
The stock has a current market capitalization of $207.18B and its 3Y-monthly beta is at 0.53. PE ratio of stock for trailing 12 months is 13.68, while it has posted earnings per share of $4.86 in the same period. Its PEG reads 8.89 and has Quick Ratio of 1.13 while making debt-to-equity ratio of 0.41. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SHEL, volatility over the week remained 1.32% while standing at 1.25% over the month.
Stock’s fiscal year EPS is expected to drop by -7.48% while it is estimated to decrease by -1.91% in next year. EPS is likely to grow at an annualized rate of 1.54% for next 5-years, compared to annual growth of 0.39% made by the stock over the past 5-years.
Coverage by Morgan Stanley stated Shell Plc ADR (SHEL) stock as an Overweight in their note to investors on January 07, 2025, suggesting a price target of $79.80 for the stock. Stock get a Neutral rating from Exane BNP Paribas on December 13, 2023.
